Evaluating the Effectiveness of Multifaceted Implementation Strategies for Implementing a Guideline for the Prevention of Common Mental Disorders at the Workplace in Schools

September 10, 2020 updated by: Lydia Kwak, Karolinska Institutet

Implementing the Swedish Guideline for the Prevention of Common Mental Disorders at the Workplace in Schools: Study Protocol of a Cluster Randomized Controlled Trial Using Multifaceted Implementation Strategies

Given today's high prevalence of common mental disorders and related sick leave among teachers an urgent need exists for a more sustainable working life for this professional group. One way of doing this is by improving schools' social and organizational risk management. Recent reports have shown that many schools in Sweden however lack a structured approach to the management of social and organizational risks. In 2015, we launched the first Swedish occupational health guideline to support a structured prevention of social and organizational risks at the workplace with the aim of preventing common mental disorders. The long-term goal of this study is to support the implementation of this guideline within schools in order to improve social and organizational risk management and in doing so reduce risk factors for mental ill-health and related sick days. The objective of the study is to fill the current research-to-practice gap by conducting a cluster-randomized controlled trial that compares the effectiveness of two implementation strategies for implementing the guideline in schools. The strategies that will be compared are training (ARM 1) versus training in combination with implementation teams and workshops (ARM 2). Our hypothesis for the study is that schools that receive support in implementing the guideline through combined strategies are more responsive to working in a structured and systematic manner with the management of social and organizational risks than schools that only receive training. The trial will be conducted in 20 primary schools in two municipalities in Sweden. All schools have agreed to participate. The primary outcomes are adherence to the guideline (implementation effectiveness) and self-reported exhaustion among schools personnel (intervention effectiveness); the secondary outcomes are risk factors for mental ill-health and absenteeism. Data will be collected at baseline, 6, 12 and 24 months by mixed methods (i.e. survey, focus-group interviews, observation, and register-data).

Study Overview

Study Type

Interventional

Enrollment (Actual)

732

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 171 77
        • Unit for Intervention and Implementation Research for Worker Health, Institute for Environmental Medicine, Karolinska Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • all individuals who are employed by the participating schools

Exclusion Criteria:

  • individuals employed by the participating municipalities and not by the participating schools, for example cleaning personal. Individuals on sick-leave

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Multifaceted implementation strategies
The school-management will participate in a one-day training. In addition each intervention school will form an implementation team that is responsible for the implementation of the guideline within their school. The implementation teams will participate in 4-5 workshops in order to support the implementation process.
The school-management will participate in a one-day training aimed at providing knowledge and skills related the recommendations of the guideline for the prevention of common mental disorders at the workplace.In addition every intervention school will form an implementation team that is responsible for the implementation of the guideline. The implementation team will comprise of approximately 3-5 individuals with experience in the field of social and organizational work environment, for example school-management and occupational health and safety representative. The implementation teams will participate in 4-5 workshops aimed at supporting the implementation process. Intervention schools within the same municipality will participate in the same workshop in order to promote peer-support.
Active Comparator: Single implementation strategy
The control-schools will only receive training to the school-management.
The school-management will participate in a one-day training aimed at providing knowledge and skills related to the recommendations of the guideline for the prevention of common mental disorders at the workplace

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Guideline adherence (implementation effectiveness)
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in adherence to the recommendations of the guideline during 6, 12 and 24 months follow-up period. We will use a questionnaire directed at the school management and a questionnaire directed at the school personnel. The questionnaires contain statements related to the recommendations in the guideline, such as "at our school we have clear and practical policies for preventing mental ill-health among our employees".
At baseline and 6, 12 and 24 months after baseline
Exhaustion (intervention effectiveness)
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in personnel's self-reported exhaustion during 6, 12 and 24 months follow. We hypothesize that adherence to the recommendations of the guideline will affect school personnel's self-reported exhaustion assessed with the Oldenburg Burnout Inventory (response format 1-4).
At baseline and 6, 12 and 24 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychosocial safety climate
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported psychosocial safety climate as assessed by the 11-items of the Psychosocial Safety Climate Scale (response format 1-5)
At baseline and 6, 12 and 24 months after baseline
Job demands
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported job-demands as assessed by 11 items of the Copenhagen Psychosocial Questionnaire (response form 1-5)
At baseline and 6, 12 and 24 months after baseline
Influence at work
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported influence at work as assessed by 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Social support colleagues
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported social support as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Possibilities for development
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported possibilities for development as assessed by 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Commitment to the workplace
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported commitment as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Social support superior
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported social support from superior as assessed by 3 items of the Copenhagen Psychosocial Questionnaire (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Work engagement
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported engagement as assessed by 3 items of the Utrecht Work Engagement Scale (response-form 1-7)
At baseline and 6, 12 and 24 months after baseline
Self-perceived health
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-perceived health as assessed with a single question (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Self-reported stress
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported stress as assessed with a single question (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Work-family conflict
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported work-family conflict as assessed with 4 items of the Copenhagen Psychosocial Questionnaire (response-form 1-4)
At baseline and 6, 12 and 24 months after baseline
Recovery
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported recovery as assessed with 1 item (response-form 1-5)
At baseline and 6, 12 and 24 months after baseline
Work performance impairment due to health problems
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in work performance as assessed by a question based on one item from the Work productivity Activity impairment - General Health Questionnaire (response format 0-10)
At baseline and 6, 12 and 24 months after baseline
Work performance impairment due to problems in the work environment
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in work performance as assessed by a question based on one item from the Work Productivity Activity Impairment - General Health Questionnaire (response format from 0-10)
At baseline and 6, 12 and 24 months after baseline
Self-reported sickness absenteeism
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline in self-reported sickness absenteeism as assessed by 2 items
At baseline and 6, 12 and 24 months after baseline
Registered sickness absenteeism
Time Frame: 12 months prior to baseline, and during 24 months after baseline
Change in total sick-leave due to common mental disorders in days, register data (sickness benefit and disability pension).
12 months prior to baseline, and during 24 months after baseline
Recognition (reward)
Time Frame: At baseline and 6, 12 and 24 months after baseline
Change from baseline self-reported collaboration and leadership as assessed by 3-items of Copenhagen Psychosocial Questionnaire (response-format 1-5)
At baseline and 6, 12 and 24 months after baseline
Self-reported stress (SMS)
Time Frame: Measured every 4th week over 12 months from baseline
Change from baseline in self-reported stress as assessed by one item sent by text-message by mobile-phone
Measured every 4th week over 12 months from baseline
Process evaluation data
Time Frame: Assessed during the 24 month study period.
Process data will be collected over the 24 months. This data will be assessed by focus-group interviews.
Assessed during the 24 month study period.
Process evaluation data
Time Frame: Assessed during the 24 month study period.
Process data will be collected over the 24 months. This data will be assessed by questionnaires
Assessed during the 24 month study period.
Process evaluation data
Time Frame: Assessed during the 24 month study period.
Process data will be collected over the 24 months. This data will be assessed by observation
Assessed during the 24 month study period.
Process evaluation data
Time Frame: Assessed during the 24 month study period.
Process data will be collected over the 24 months. This data will be assessed by documentation.
Assessed during the 24 month study period.
Barriers
Time Frame: Assessed during the 24 month study period
Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by focus-group interviews
Assessed during the 24 month study period
Barriers
Time Frame: Assessed during the 24 month study period
Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by questionnaires
Assessed during the 24 month study period
Barriers
Time Frame: Assessed during the 24 month study period
Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by observation
Assessed during the 24 month study period
Barriers
Time Frame: Assessed during the 24 month study period
Information will be collected on possible barriers that may have influenced the implementation process. This data will be assessed by documentation.
Assessed during the 24 month study period
Facilitators
Time Frame: Assessed during the 24 month study period
Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by focus-group interviews
Assessed during the 24 month study period
Facilitators
Time Frame: Assessed during the 24 month study period
Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by questionnaires
Assessed during the 24 month study period
Facilitators
Time Frame: Assessed during the 24 month study period
Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by observation
Assessed during the 24 month study period
Facilitators
Time Frame: Assessed during the 24 month study period
Information will be collected on possible facilitators that may have influenced the implementation process. This data will be assessed by documentation.
Assessed during the 24 month study period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2017

Primary Completion (Actual)

October 30, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

September 19, 2017

First Submitted That Met QC Criteria

October 23, 2017

First Posted (Actual)

October 26, 2017

Study Record Updates

Last Update Posted (Actual)

September 14, 2020

Last Update Submitted That Met QC Criteria

September 10, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

The ethical approval does not allow data-sharing of individual participation data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Common Mental Disorders

Clinical Trials on Multifaceted implementation strategies

3
Subscribe